Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.50
Bid: 146.50
Ask: 147.50
Change: 3.50 (2.43%)
Spread: 1.00 (0.683%)
Open: 144.00
High: 149.00
Low: 142.00
Prev. Close: 144.00
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

23 May 2024 15:44

RNS Number : 7208P
Bakkavor Group PLC
23 May 2024
 

23 May 2024

Bakkavor Group plc

(the 'Company')

 

2024 Annual General Meeting - Poll Results

The Company's 2024 Annual General Meeting ("AGM") was held today at 10.00 am at Fitzroy Place, 5th Floor, 8 Mortimer Street, London, W1T 3JJ. All resolutions set out in the Notice of AGM dated 4 March 2024 and put to the meeting were decided on by a poll and were passed.

 

Resolutions 1 to 18 were each passed as an Ordinary Resolution (requiring a simple majority for them to be passed) and resolutions 19 to 22 were each passed as a Special Resolution (requiring at least a 75% majority for them to be passed). The results for each resolution are set out below.

 

Res No.

Resolution

Votes For and Discretionary Votes

%

Votes Against

%

Total Votes Cast (Excluding Withheld)

% of ISC Voted *

Votes Withheld

1.

To receive the 2023 Annual Report and Accounts

557,183,171

100.00%

10,638

0.00%

557,193,809

96.16

7,689

2.

To approve the Directors' Remuneration Report

556,747,334

99.92%

440,095

0.08%

557,187,429

96.16

14,069

3.

To approve the 2024 Directors' Remuneration Policy

557,116,484

99.99%

70,788

0.01%

557,187,272

96.16

14,226

4.

To declare a final dividend for the year ended 30 December 2023 of 4.37 pence per ordinary share

557,184,529

100.00%

8,998

0.00%

557,193,527

96.16

7,971

5.

To elect Robert Berlin as a Director of the Company

557,154,228

99.99%

37,581

0.01%

557,191,809

96.16

9,689

6.

To re-elect Simon Burke as a Director of the Company

549,389,394

98.60%

7,802,415

1.40%

557,191,809

96.16

9,689

7.

To re-elect Mike Edwards as a Director of the Company

557,153,965

99.99%

37,021

0.01%

557,190,986

96.16

10,512

8.

To re-elect Ben Waldron as a Director of the Company

557,154,170

99.99%

37,639

0.01%

557,191,809

96.16

9,689

9.

To re-elect Sanjeevan Bala as a Director of the Company

557,158,913

99.99%

32,896

0.01%

557,191,809

96.16

9,689

10.

To re-elect Umran Beba as a Director of the Company

554,788,767

99.57%

2,403,042

0.43%

557,191,809

96.16

9,689

11.

To re-elect Jill Caseberry as a Director of the Company

554,806,624

99.57%

2,381,580

0.43%

557,188,204

96.16

13,294

12.

To re-elect Agust Gudmundsson as a Director of the Company

557,156,484

99.99%

34,502

0.01%

557,190,986

96.16

10,512

13.

To re-elect Lydur Gudmundsson as a Director of the Company

554,765,171

99.56%

2,426,638

0.44%

557,191,809

96.16

9,689

14.

To re-elect Denis Hennequin as a Director of the Company

554,783,527

99.57%

2,404,677

0.43%

557,188,204

96.16

13,294

15.

To re-elect Jane Lodge as a Director of the Company

557,154,458

99.99%

33,746

0.01%

557,188,204

96.16

13,294

16.

To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company

557,186,465

100.00%

10,667

0.00%

557,197,132

96.16

4,366

17.

To authorise the Audit & Risk Committee to determine the remuneration of the Auditors

557,183,456

100.00%

13,676

0.00%

557,197,132

96.16

4,366

18.

To authorise the Directors to allot shares

557,139,470

99.99%

54,873

0.01%

557,194,343

96.16

7,155

19.

To empower the Directors to disapply pre-emption rights

556,988,011

99.96%

206,332

0.04%

557,194,343

96.16

7,155

20.

To empower the Directors to disapply pre-emption rights for financing/refinancing particular acquisitions and other capital investments

556,968,453

99.96%

225,890

0.04%

557,194,343

96.16

7,155

21.

To authorise the Company to purchase its own shares

555,029,024

99.61%

2,168,108

0.39%

557,197,132

96.16

4,366

22.

 

To allow a general meeting to be called on 14 clear days' notice

 

 

556,964,866

99.96%

226,411

0.04%

557,191,277

96.16

10,221

 

* Based on total issued share capital as at 21 May 2024 of 579,425,585 Ordinary shares.

 

Votes of Independent Shareholders on the resolutions concerning the re-election of the Independent Non-executive Directors

Res No.

Resolution

Votes For and Discretionary Votes

%

Votes Against

%

Total Votes Cast

% of ISC Voted **

Votes Withheld

6.

To re-elect Simon Burke as a Director of the Company

258,724,634

97.07%

7,802,415

2.93%

266,527,049

92.36

9,689

9.

To re-elect Sanjeevan Bala as a Director of the Company

266,494,153

99.99%

32,896

0.01%

266,527,049

92.36

9,689

10.

To re-elect Umran Beba as a Director of the Company

264,124,007

99.10%

2,403,042

0.90%

266,527,049

92.36

9,689

11.

To re-elect Jill Caseberry as a Director of the Company

264,141,864

99.11%

2,381,580

0.89%

266,523,444

92.36

13,294

 14.

To re-elect Denis Hennequin as a Director of the Company

264,118,767

99.10%

2,404,677

0.90%

266,523,444

92.36

13,294

15.

To re-elect Jane Lodge as a Director of the Company

266,489,698

99.99%

33,746

0.01%

266,523,444

92.36

13,294

 

** Based on independent voting capital of 288,560,825, being total issued share capital of 579,425,585 Ordinary shares as at 21 May 2024, but 

excluding shares held by the controlling shareholders.

 

 

 

Notes:

a) The votes "For" and "Against" are expressed as a percentage of the votes received.

b) The Company's issued share capital as at 21 May 2024 is 579,425,585 ordinary shares of 2 pence each.

c) The Company's issued share capital as at 23 May 2024 is 579,425,585 ordinary shares of 2 pence each.

d) Where shareholders have appointed the Chairman of the meeting as their proxy with discretion as to voting, those votes have been cast in favour of all of the resolutions.

e) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" a resolution.

f) In accordance with Listing Rule 9.2.2E, Resolutions 6, 9, 10, 11, 14 and 15 (re-election of independent directors) inclusive were approved by: (a) the shareholders of the Company; and (b) the independent shareholders of the Company.

g) In accordance with Listing Rule 9.6.2, a copy of all resolutions passed other than resolutions concerning ordinary business will be submitted to the FCA via the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

-Ends-

 

ENQUIRIES

 

 

Company Secretarial:

Annabel Tagoe-Bannerman, Group General Counsel and Company Secretary

+44 (0) 20 7908 6130

Institutional investors and analysts:

Ben Waldron, Chief Financial Officer

Emily Daw, Head of Investor Relations

+44 (0) 20 7908 6114

 

About Bakkavor

We are the leading provider of fresh prepared food in the UK, and our presence in the US and China positions the Group well in these high-growth markets. We leverage our consumer insight and scale to provide innovative food that offers quality, choice, convenience, and freshness. Around 18,000 colleagues operate from 43 sites across our three markets supplying a portfolio of over 3,000 products across meals, pizza & bread, salads and desserts to leading grocery retailers in the UK and US, and international food brands in China. Find out more at www.bakkavor.com

LEI number: 213800COL7AD54YU9949

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUOSSRSOUVUAR
Date   Source Headline
23rd May 20243:44 pmRNSResult of AGM
23rd May 20247:00 amRNSQ1 2024 Trading Update
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.